# Top 50 Biotechnology VC (Venture Capital) Funds in Europe in June 2026 ## SOSV - Type: VC Fund - Location: Princeton, New Jersey, United States - Relevant deals: 77 - Stages: Seed, Convertible Note, Pre-Seed - Focus: Biotechnology, Health Care, Software SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment. ## Bpifrance - Type: VC Fund - Location: Maisons-alfort, Ile-de-France, France - Relevant deals: 73 - Stages: Seed, Series A - Focus: Software, Information Technology, Health Care Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business. ## Sofinnova Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 69 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. ## UK Innovation & Science Seed Fund - Type: VC Fund - Location: Harwell, Oxfordshire, United Kingdom - Relevant deals: 56 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Medical UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs ## HTGF (High-Tech Gruenderfonds) - Type: VC Fund - Location: Bonn, Nordrhein-Westfalen, Germany - Relevant deals: 54 - Stages: Seed, Series A - Focus: Software, Biotechnology, Information Technology High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors. ## Novo Holdings - Type: VC Fund - Location: Hellerup, Hovedstaden, Denmark - Relevant deals: 51 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Novo Holdings is a world-leading life science investor with a focus on creating long-term value. ## Parkwalk Advisors - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 44 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Health Care, Software Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn. ## Scottish Enterprise - Type: VC Fund - Location: Glasgow, Glasgow City, United Kingdom - Relevant deals: 43 - Stages: Seed, Grant - Focus: Biotechnology, Software, Health Care Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today. ## Oxford Science Enterprises - Type: VC Fund - Location: Oxford, Oxfordshire, United Kingdom - Relevant deals: 40 - Stages: Seed, Series A, Series B - Focus: Health Care, Biotechnology, Software Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent. ## Kurma Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 35 - Stages: Series A, Seed, Series B - Focus: Health Care, Biotechnology, Medical Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals. ## Seventure Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 35 - Stages: Series A, Series B - Focus: Biotechnology, Software, Health Care Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy ## Oxford Technology Management - Type: VC Fund - Location: Oxford, Oxfordshire, United Kingdom - Relevant deals: 34 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Software Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free. ## Boehringer Ingelheim Venture Fund - Type: VC Fund - Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany - Relevant deals: 31 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine ## Enterprise Ireland - Type: VC Fund - Location: Dublin, Dublin, Ireland - Relevant deals: 29 - Stages: Seed, Series A - Focus: Software, Health Care, Information Technology Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland. ## Catapult Ventures - Type: VC Fund - Location: Leicester, Leicester, United Kingdom - Relevant deals: 29 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment. ## Scottish Investment Bank - Type: VC Fund - Location: Glasgow, Glasgow City, United Kingdom - Relevant deals: 28 - Stages: Seed, Series A - Focus: Software, Biotechnology, Health Care Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business. ## Mercia Fund Managers - Type: VC Fund - Location: Henley In Arden, Warwickshire, United Kingdom - Relevant deals: 27 - Stages: Seed, Series A - Focus: Software, Health Care, Biotechnology Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit. ## GO CAPITAL - Type: VC Fund - Location: Rennes, Bretagne, France - Relevant deals: 26 - Stages: Seed, Series A - Focus: Biotechnology, Software, Health Care GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future. ## M Ventures - Type: VC Fund - Location: Amsterdam, Noord-Holland, The Netherlands - Relevant deals: 25 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base. ## Epidarex Capital - Type: VC Fund - Location: Bethesda, Maryland, United States - Relevant deals: 25 - Stages: Series A, Seed, Series B - Focus: Biotechnology, Health Care, Therapeutics Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities. ## Development Bank of Wales - Type: VC Fund - Location: Cardiff, Cardiff, United Kingdom - Relevant deals: 24 - Stages: Seed, Debt Financing - Focus: Software, Health Care, Biotechnology Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds. ## Centre for the Development of Industrial Technology (CDTI) - Type: VC Fund - Location: Madrid, Madrid, Spain - Relevant deals: 24 - Stages: Grant, Seed - Focus: Biotechnology, Health Care, Software The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int . ## Elaia - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 24 - Stages: Seed, Series A, Series B - Focus: Software, Artificial Intelligence, Information Technology Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors. ## Karista - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 23 - Stages: Seed, Series A, Series B - Focus: Software, Biotechnology, Health Care Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace. ## SFC Capital - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 22 - Stages: Pre-Seed, Seed - Focus: Software, Artificial Intelligence, Information Technology Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital. ## Archangels - Type: VC Fund - Location: Edinburgh, Edinburgh, City of, United Kingdom - Relevant deals: 22 - Stages: Seed, Series A - Focus: Software, Biotechnology, Health Care Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK. ## Forbion Capital Partners - Type: VC Fund - Location: Naarden, Noord-Holland, The Netherlands - Relevant deals: 22 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Medical Impacting the future of medicine. ## HealthCap - Type: VC Fund - Location: Stockholm, Stockholms Lan, Sweden - Relevant deals: 21 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Medical HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society. ## BioInnovation Institute - Type: VC Fund - Location: Copenhagen, Hovedstaden, Denmark - Relevant deals: 21 - Stages: Convertible Note, Pre-Seed, Debt Financing - Focus: Biotechnology, Medical, Health Care BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark. ## MIG Capital - Type: VC Fund - Location: München, Bayern, Germany - Relevant deals: 21 - Stages: Series A, Series B - Focus: Biotechnology, Health Care, Therapeutics MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies. ## IP Group - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 21 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Therapeutics IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders. ## Omnes Capital - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 21 - Stages: Series A, Series B - Focus: Software, Biotechnology, Health Care Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar. ## Auriga Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 20 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Medical Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences. ## AlbionVC - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 20 - Stages: Series A, Seed - Focus: Software, Information Technology, Health Care AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/ ## O2h Ventures - Type: VC Fund - Relevant deals: 20 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Pharmaceutical Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success. ## Future Planet Capital - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 20 - Stages: Seed, Convertible Note - Focus: Biotechnology, Health Care, Software Brilliant Ideas. Brilliant People. Brilliant Minds. ## Meusinvest (Noshaq) - Type: VC Fund - Location: Liège, Liege, Belgium - Relevant deals: 20 - Stages: Series A, Seed - Focus: Biotechnology, Health Care, Medical Noshaq offers financial services to help businesses develop. ## Idinvest Partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 19 - Stages: Series B, Series A - Focus: Biotechnology, Health Care, Software Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more. ## Wren Capital - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 19 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Medical Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so. ## Deepbridge Capital - Type: VC Fund - Location: Chester, Cheshire, United Kingdom - Relevant deals: 19 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses. ## GM&C Life Sciences Fund - Type: VC Fund - Location: Alderley Edge, Cheshire, United Kingdom - Relevant deals: 19 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships. ## Northstar Ventures - Type: VC Fund - Location: Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom - Relevant deals: 19 - Stages: Seed, Series A - Focus: Software, Health Care, E-Commerce Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing. ## Newable Private Investing - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 18 - Stages: Seed, Series A - Focus: Software, Health Care, Biotechnology Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution ## Cambridge Innovation Capital - Type: VC Fund - Location: Cambridge, Cambridgeshire, United Kingdom - Relevant deals: 18 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Therapeutics As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact. ## Hoxton Ventures - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 18 - Stages: Seed, Series A - Focus: Artificial Intelligence, Software, Information Technology Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe. ## AdBio partners - Type: VC Fund - Location: Paris, Ile-de-France, France - Relevant deals: 17 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Pharmaceutical AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem. ## Ysios Capital - Type: VC Fund - Location: San Sebastian, Pais Vasco, Spain - Relevant deals: 17 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide. ## Oxford Capital - Type: VC Fund - Location: Oxford, Oxfordshire, United Kingdom - Relevant deals: 17 - Stages: Seed, Series A - Focus: Software, Health Care, Mobile Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999. ## Syncona Partners LLP - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 16 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Medical, Health Care Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need. ## Octopus Ventures - Type: VC Fund - Location: London, England, United Kingdom - Relevant deals: 16 - Stages: Series A, Seed, Series B - Focus: Software, Health Care, Information Technology We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.